• Home
  • Alpha-fetoprotein slope over 7.5 ng/ml over 3 months before liver transplantation for hepatocellular carcinoma predicts recurrence even after controlling for alpha-fetoprotein at liver transplantation.

Alpha-fetoprotein slope over 7.5 ng/ml over 3 months before liver transplantation for hepatocellular carcinoma predicts recurrence even after controlling for alpha-fetoprotein at liver transplantation.

Author List
Giard JM, Dodge JL, Yao FY, Mehta N
Publication
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Publication ID (Profile URL)
https://researcherprofiles.org/profile/313213738
Publication Year
2023
PubMed ID
35809249
Publication Title
Giard JM, Dodge JL, Yao FY, Mehta N. Alpha-fetoprotein slope over 7.5 ng/ml over 3 months before liver transplantation for hepatocellular carcinoma predicts recurrence even after controlling for alpha-fetoprotein at liver transplantation. Liver Transpl. 2023 02 01; 29(2):233-235.